Showing results (31-40 of 37) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Cancers|February 24, 2024
Filamin A Is a Prognostic Serum Biomarker for Differentiating Benign Prostatic Hyperplasia from Prostate Cancer in Caucasian and African American MenNischal Mahaveer Chand, Poornima K Tekumalla, Matt T Rosenberg, et al.Biorxiv : the Preprint Server for Biology|June 4, 2026
Stage-Specific Regulation of DNA Damage Repair by the Circadian Regulator, CRY1, in Prostate CancerArwa Fallatah, Stefan DiFazio, Lakshmi Ravindranath, et al.Genes & Cancer|February 14, 2017
Autoantibodies against oncogenic ERG protein in prostate cancer: potential use in diagnosis and prognosis in a panel with C-MYC, AMACR and HERV-K GagAnshu Rastogi, Amina Ali, Shyh-Han Tan, et al.Prostate Cancer and Prostatic Diseases|December 14, 2018
Increased frequency of germline BRCA2 mutations associates with prostate cancer metastasis in a racially diverse patient populationGyorgy Petrovics, Douglas K Price, Hong Lou, et al.Journal of Translational Medicine|January 9, 2020
Multi-omic serum biomarkers for prognosis of disease progression in prostate cancerMichael A Kiebish, Jennifer Cullen, Prachi Mishra, et al.Nature Communications|March 16, 2022
Germline mutation landscape of DNA damage repair genes in African Americans with prostate cancer highlights potentially targetable RAD genesIndu Kohaar, Xijun Zhang, Shyh-Han Tan, et al.Scientific Reports|July 24, 2021
Clinical utility of a serum biomarker panel in distinguishing prostate cancer from benign prostate hyperplasiaMichael A Kiebish, Poornima Tekumalla, Shobha Ravipaty, et al.Pageof 4